MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

White matter connectome in patients with genetic dystonia

S. Basaia, F. Agosta, A. Tomic, E. Sarasso, N. Kresojevic, S. Galantucci, M. Svetel, V. Kostic, M. Filippi (Milano, Italy)

Meeting: 2016 International Congress

Abstract Number: 1690

Keywords: Dystonia: Genetics

Session Information

Date: Thursday, June 23, 2016

Session Title: Dystonia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: This study investigated structural neural pathways in clinically manifesting and non-manifesting individuals with several dystonia (DYT) genotypes using a network approach.

Background: DYT has traditionally been attributed to basal ganglia dysfunction. Recent studies expanded this picture suggesting DYT as a circuit disorder.

Methods: We included 9 asymptomatic mutation carriers (4 DYT1, 4 DYT6, 1 DYT10), 26 symptomatic mutation carriers (7 DYT1, 7 DYT6, 9 DYT5, 1 DYT18, 1 DYT10, 1 DYT25) and 37 healthy controls (HC). Subjects underwent 3D T1-weighted and diffusion tensor (DT) MRI. The human macroscale connectome was constructed from DT MRI. Tissue segmentation was performed on T1-weighted images using Freesurfer. The affected structural connections in DYT samples were investigated using Network-Based Statistic (p<0.01, 10.000 permutations).

Results: Compared to HC, asymptomatic mutation carriers showed a basal ganglia/frontal subnetwork characterized by decreased fractional anisotropy and increased mean diffusivity (MD) including the left putamen, precentral gyrus, middle and superior frontal gyri, middle temporal, and insula, while clinically manifesting DYT mutation carriers showed an altered subnetwork characterized by increased MD connecting left putamen, middle and superior frontal gyri, orbitofrontal cortex, middle temporal, insula and right anterior cingulate cortex. No differences were found between symptomatic and asymptomatic DYT subjects. A trend toward a greater disconnection was observed in symptomatic DYT1 relative to DYT6 subjects.

Conclusions: Our findings suggest that structural brain abnormalities in both clinically manifesting and non-manifesting DYT mutation carriers are distributed at a network level, beyond the basal ganglia/sensorimotor cortex regions. Studying of asymptomatic mutation carriers offered the possibility of identifying genotype-related trait characteristics without the confound of clinical symptoms providing new insights into understanding DYT generation.

XLVI Congress of Italian Neurological Society.

To cite this abstract in AMA style:

S. Basaia, F. Agosta, A. Tomic, E. Sarasso, N. Kresojevic, S. Galantucci, M. Svetel, V. Kostic, M. Filippi. White matter connectome in patients with genetic dystonia [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/white-matter-connectome-in-patients-with-genetic-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/white-matter-connectome-in-patients-with-genetic-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley